Revealing the missing links in the chain of relevant information from the clinicians to pathologists
Abbas Ghaffari, Shagufta Nasir Pervez, Zia ur Rehman, Bakhtawar Kamal

TL;DR
This study found that while patient identifiers are well-recorded on biopsy forms, important clinical and specimen details are often missing, affecting communication between clinicians and pathologists.
Contribution
The study quantifies gaps in information transfer between clinicians and pathologists using biopsy requisition forms in a specific healthcare setting.
Findings
Patient identifiers like name and medical record number were present on nearly all forms, but clinical history and specimen details were missing on many.
Only 24% of forms included the requesting doctor's name, and no form had all 20 required variables.
The mean percentage of documented variables was 39.76%, indicating significant room for improvement in information completeness.
Abstract
To evaluate the adequacy of demographic, clinical, and specimen-related information provided to the histopathology laboratory. Total 400 biopsy requisition forms were studied retrospectively for the presence and absence of 20 different variables. This cross-sectional and single-centric study was conducted in a tertiary care setting in Peshawar Pakistan in year 2024. Data was collected in Microsoft Excel and analyzed with SPSS v.22. Frequencies, percentages, and mean percentage of the documented variables were determined. Scoring the documented variable as one and the undocumented variable as zero, RFs were scored out of a total score of 20 and mean score was calculated. Only the name was written on 100% of forms, followed by MRN (95.5%), and the investigation required (91.25%). However, only 36% and 35.75% of forms contained the patient’s age and gender respectively. Essential…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
| Variable | Yes | No | Yes% | No% |
|---|---|---|---|---|
| Name | 400 | 0 | 100 | 0 |
| MR NO | 382 | 18 | 95.5 | 4.5 |
| Age | 144 | 256 | 36 | 64 |
| Gender | 143 | 257 | 35.75 | 64.25 |
| Address | 24 | 376 | 6 | 94 |
| Patient contact | 170 | 230 | 42.5 | 57.5 |
| Ward | 153 | 247 | 38.25 | 61.75 |
| Bed No | 52 | 348 | 13 | 87 |
| Clinical History | 329 | 71 | 82.25 | 17.75 |
| Presumptive Diagnosis | 92 | 308 | 23 | 77 |
| Operative Findings | 25 | 375 | 6.25 | 93.75 |
| Radiological Findings | 9 | 391 | 2.25 | 97.75 |
| Procedure | 244 | 156 | 61 | 39 |
| Specimen Nature | 110 | 290 | 27.5 | 72.5 |
| Site of Biopsy | 201 | 199 | 50.25 | 49.75 |
| Date of Biopsy | 110 | 290 | 27.5 | 72.5 |
| Required Investigation | 365 | 35 | 91.25 | 8.75 |
| Ordering Surgeon | 96 | 304 | 24 | 76 |
| Surgeon contact | 16 | 384 | 4 | 96 |
| Doctor’s Sign | 116 | 284 | 29 | 71 |
| Score | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Frequency | 6 | 24 | 53 | 64 | 55 | 47 | 26 | 44 | 28 | 25 | 19 | 7 | 2 |
| Percent | 1.5 | 6 | 13.3 | 16 | 13.8 | 11.8 | 6.5 | 11 | 7 | 6.3 | 4.8 | 1.8 | 0.5 |
| Variable (%) | Our Study | J L Burton et al. | Fariba Abbasi et al. | Dr Priyadharisini et al. | Mishaal Shan Siddiqui et al. | Muhammad Ashraf Sharif et al. |
|---|---|---|---|---|---|---|
| Sample size | n=400 | n=2000 | n=2040 | n=114 | n=175 | n=500 |
| Name | 100 | 100 | 99.8 | 100 | 99.4 | NA |
| Medical Record No | 95 | 99.8 | NA | 100 | 64.6 | NA |
| Age | 27 | 99.6 | 91.96 | 98.3 | NA | 94.2 |
| Gender | 31 | NA | 72.25 | 98.3 | 93.7 | 86 |
| Address | 5 | 93.1 | NA | NA | NA | NA |
| Patient contact number | 44 | NA | 93.8 | NA | 28 | NA |
| Ward | 35.6 | NA | NA | 85 | 97.7 | NA |
| Bed No | 10 | NA | NA | NA | 52.8 | NA |
| Procedure | 65 | NA | NA | 89.4 | NA | NA |
| Specimen Nature | 26 | 98.9 | 12.1 | NA | 74.9 | NA |
| Site of Biopsy | 43 | NA | 92.8 | 77 | 87 | 87 |
| Date of Biopsy | 25 | 98.2 | NA | 100 | NA | NA |
| Clinical History | 80.7 | 93.9 | 80 | 35 | 82.3 | 64 |
| Differential Diagnosis | 25 | 53.1 | 82.6 | 94.7 | 93.7 | |
| Operative Findings | 3 | NA | NA | NA | 53.7 | NA |
| Radiological Findings | 2 | NA | 5.2 | Included in Previous Investigations | 9.1 | NA |
| Doctor Name | 19.8 | 47.5 | 98.7 | 38.5 | 98.3 | 77 |
| Surgeon contact | 3 | 33.3 | 0.05 | NA | 19.4 | |
| Doctor’s Sign | 28 | 91.5 | NA | 100 | NA | |
| Investigation Requested | 98 | 97.4 | NA | NA | NA | NA |
| Previous Investigations | NA | NA | 12.5 | 30.7 | 18.9 | NA |
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsAI in cancer detection · Medical Coding and Health Information · Biomedical Text Mining and Ontologies
INTRODUCTION
Biopsy is the gold standard for diagnosing lesions at the tissue level. A biopsy requisition form (RF) is the first communication between the requesting doctor and a pathologist. Ideally, for a swift and accurate definitive diagnosis in fewer resources, the provision of adequate demographic, clinical and specimen-related information to the pathologist is necessary. On the contrary, lack of the said information is a matter of great concern for pathologists around the globe, for it may increase the chances of wrong patient identification, erroneous diagnosis, false reporting, increased turnaround time (TAT),1,2 human errors,3 increased human efforts,2 and increased resource consumption.2,4,5
In our country Pakistan, only a few studies have been published that provide insight into whether the information of the patient provided to pathologists by the clinicians is sufficient or not and how this lack of information affects the diagnosis and reporting in pathology. However, these studies do not give a comprehensive overview of all the needed information to the pathologists. Therefore, studies to quantify the adequacy of demographic and clinical data provided to the pathologists are much needed in Pakistan. Our study provides the relevant statistical data on this subject however studies about its resultant errors and other implications are still much needed.
Our study provide the relevant and comprehensive statistical data on the subject. The results were compared to those of neighboring countries and the United Kingdom. Also, in our study, we have discussed the importance of all the necessary information needed to the pathologists that would, otherwise, be look irrelevant to a maximum number of doctors requesting a biopsy. Moreover, many possible reasons behind the scarcity of the said data and its possible impact on the diagnosis-making process, in the light of already available literature, are discussed in this article.
METHODS
This retrospective single-centric study was conducted to quantify the demographic, clinical and specimen-related data provided to the pathologist and to check its adequacy at Histopathology laboratory in a tertiary care hospital in Peshawar in year 2024.
Sample size:
The sample size was calculated using the online WHO calculator 1.1, with a population proportion of 0.5, a confidence interval of 0.95, and a margin of error 0.05. The calculated sample size for the study was 385 RFs which is rounded off to 400 RFs.
Inclusion criteria:
- RFs sent for tissue biopsies in the year 2024.
Exclusion criteria:
- RFs for trephine biopsies and cytology were excluded as their RFs are different from the biopsy RF.
- Biopsy RFs received before the first of January 2024 and after 31^st^ December 2024.
Sampling Technique:
Four hundred RFs sent from different wards, were selected with convenient non-probability sampling technique.
Data collection:
Biopsy RFs were retrieved within the laboratory and studied for the presence of 20 variables comprising of name, age, gender, address, contact number of the patient, ward, bed number, medical record (MR) number, clinical history, presumptive clinical diagnosis, procedure, intra-operative findings, radiological findings, specimen nature, site of biopsy, the date on which biopsy is taken, ordering surgeon/physician’s name, sign, contact number, and the investigation required. On each RF, the presence of the above-mentioned variables was studied.
Steps of measurement of variables:
The data was collected directly into the Microsoft Excel. Even a bit of information was considered and categorized as “Yes” if provided, and “No” if not provided. Where a doctor used his stamp, it is considered as information about his name, ward and signature. If a variable was present on the RF, it was given a score of one and a score of zero if absent. Each RF got a particular score.
Data analysis:
The compiled data was then analyzed with SPSS version 22. The adequacy of information regarding each variable was determined in terms of frequency and percentages. The adequacy of the overall information provided to the pathologist was determined by calculating the mean of the percentages of the individual variables. Frequency, percentage and a mean of the cumulative scores were calculated, which showed how many and how much, individual RFs were filled.
Ethical approval:
The study was approved by the Ethical Review Committee/IREB on 6^th^ January 2025 under the reference number 2372.
RESULTS
Out of 2301 biopsy requests received in the year 2024, we selected 400 RFs (n=400). Among these 400 RFs, 278 RFs (69.5%) were sent from Gynaecology and Obstetrics, while 118 RFs (29.5%) were sent from other General Surgery and Allied wards i.e. Plastic Surgery, Neurosurgery, ENT, Cardiac Surgery, Urology, Thoracic Surgery and Orthopedics wards. Four RFs (1%) were sent from Medical & Allied wards i.e. Medicine, Pediatrics and Oncology wards. Only name was the variable that was written on all (100%) of RFs, followed by MRN and the investigation required, with frequencies of 382 (95.5%), and 365 (91.25%) respectively. Clinical history, was present only on 329 (82.25%) RFs while only 92 (23%) RFs had the presumptive diagnosis. Only 9 (2.25%) RFs had radiological findings written on the RF (Table-I). There was not a single RF that had all the required data documented. When mean of the percentages of all variables were calculated, it came out to be 39.76%. Moreover, each variable, if present on an individual RF was scored as one and if absent, scored as zero, giving a collective score out of a total score of 20 for each individual RF (Table-II). A score of six was the most common which has a frequency of 64 (16%). The minimum score was three and the maximum was fifteen. Not a single RF scored 20 out of 20. The mean of this cumulative score was calculated, and it came out to be 7.95±2.74.
DISCUSSION
Ideally, for a correct identification of the patient, there must be at least two identifiers on the RF as well as on the specimen container.6,7 Similarly the clinical history of the patient and findings regarding the specimen is the most essential data and should be provided on each and every RF. In our study, name was the only variable that was present on 100% of RFs, followed by the MRN (95.5%). Three hundred and fifty (87.5%) RFs contained both the name and MRN. In the rest of 50 RFs, 48 (12%) had another identifier like age, gender, address, or patient contact number. Only two RFs (0.5%) had only one identifier. Collectively, 99.5% of RFs were following the criteria. The required investigation, present on 365 (91.25%) RFs was the third most frequently provided data. Despite that mere a chief complaint was also considered as a clinical history, it was present only on 329 (82.25%) RFs and most of the times, inconclusive. The procedure done (61%), intraoperative findings (6.25%), radiological findings (2.25%) and presumptive diagnosis (23%) were also not up to the mark. Similarly, nature (27.5%), site (50.25%) and date of the specimen collection (27.5%) as well as the personal data of the ordering physician was inadequate in our study (Table-I).
A clinical audit conducted in Pakistan revealed that name, MRN and gender were stated on 99.4%, 64.6% and 93.7% of RFs respectively but the clinical history, operative findings and radiological findings were only available on 82.3%, 53.7% and 9.1% RFs respectively.8 In an another study conducted in Pakistan, age and gender were mentioned on 94% and 86% of RFs respectively but the clinical history was reported to be present on 64% RFs only.9 In a study conducted in India, these four variables viz name, age, gender, and IP/OP number (IP/OP: In-patient/out-patient number equivalent to MRN in our study) were stated on 100%, 98.3%, 98.3%, and 100% of RFs respectively while clinical history on 35% of RFs only.10 The counts are better in the study conducted by J.L. Burton and T.J. Stephenson.11 Fariba Abbasi et. al. reports the patient’s identifiers and demographic data like name, age and gender were written on 99.8%, 91.96%, and 72.5% of RFs respectively but clinical history on 80% RFs only. A more detailed comparison can be seen in Table-III. This comparison suggests that the clinicians were more compliant to provide at least two identifiers of the patient however the counts of clinical and specimen-related information were markedly below the benchmarks.
Deficient and inadequate information may contribute to erroneous biopsy reports. A study conducted in the United States shows that among 60043 deficient RFs, wrong specimen identifiers contributed to 9.6% of errors while discrepant or missing information was implicated in 77% of errors.12 A study in Thailand, finds 26.81% cases of erroneous diagnosis due to wrong patient identification.13 Another study in Portugal reveals that in a sample of 10574 cases, 330 cases (3.1%) were found with errors. Among these errors, 65% were related to RFs, i.e. absence of RFs (10.6%), patient identifiers (1.2%), clinical information (15.8%), sample identification (35.1%), and clinician identification (2.1%).14 Siddiqui MS et al. reports that among the inconclusive biopsy reports, 78% had incompletely filled RFs.8 A famous study titled as “Clinicians Are From Mars and Pathologists Are From Venus” reveals that clinicians usually misinterpret such reports.15
The potential reason behind the adequacy of patient’s identifier’s data and that of investigation required may be attributed to the software used in the hospital i.e. HMIS (Hospital Management Information System), the minimum requirements for which is the name, MRN and the investigation to be ordered. Development and improvement in such software may improve clinical information delivery, and reduce the risks of errors and turn-around time.16,17 Also the identifiers are the least information required in a laboratory and the receptionist ensure its availability more religiously.
The inadequate clinical and specimen related information may be due to the increased workload on the doctors.18 It also puts a question mark on the concept of the doctors about the biopsies and their requirements. Non-availability of the specified biopsy RFs may also be a potential reason.19 Moreover, sometimes, the clinicians keep the pathologist blind intentionally, ignoring the fact that this blindness may affect the precision of definitive diagnosis.
In the absence of a clear clinical context, decision-making among many potential diagnoses such as benign versus malignant tumors or reactive versus neoplastic lesions, becomes increasingly difficult. For instance, a granuloma in a tissue may be of infective or inflammatory origin, may be due to a foreign body, due to a certain drug, or may be in a setting of neoplasia.20-22 The radiological findings are specially much needed in neural tissue biopsies,23 and bone biopsies.24 Specimen nature and description of the laterality are both necessary for reporting on the margins of the tumor and where tumor grading is required because, in comparison to excisional biopsy, there are high chances that high grade tumor cells may be missed in Fine Needle Aspiration or Punch biopsies. The site of the lesion is important where the tissues have the similar surface epithelium or where the tissue architecture is distorted or making the right choice of Immuno-Histo-Chemical (IHC) marker to be applied especially when one try to decide about the origin of tumor25 and type of tumor as some markers may come positive in many tumors. Without the information of the site of the biopsy the pathologist may start with a wide range of markers which itself carries the risk of false positives beside that the expenses and turnaround time increases.
Although many studies are published on this subject in the region, we think our study has some relative strengths given as following:
- The sample size is adequate and was properly calculated using WHO calculator.
- The methodology and data is reproducible.
- A proper comparison was made with other similar studies published in the region and in a setting of standard health system like United Kingdom.
- Each individual RF was scored and a mean score represented the amount of provided information on the majority of RFs.
- Recommendations for improvement were given.
Limitations:
Following are the limitations we faced in our study:
- The study was a retrospective and single centric study. Future studies should be prospective to represent the real time situation. Also the practices may vary center to center.
- The sampling technique is Convenient Non-probability sampling method.
- Majority of the RFs were sent from Gynecology and Obstetrics and RFs from other departments are relatively smaller in number.
- RFs were not specifically designed for biopsy requests. The RFs studied was general and for all type investigations, lacking a specific field for some of the variables.
- Even the chief complaint of the patient was considered as a clinical history while an adequate clinical history contain many modalities.
- The errors caused by inadequacy of clinical and specimen information could not be studied due to the retrospective design of the study and non-availability of the record of errors.
- Statistically significant association of the said inadequate information with specific reasons could not be studied.
CONCLUSION
The patient’s demographic, clinical and specimen-related information provided to the pathologists along with biopsy requests, was inadequate. Though the doctors seemed to be more compliant to provide patient identifiers, they did not provide enough clinical history, their findings and also their own information. This much scarcity of clinical and demographic information significantly contributes to many types of errors in the process of diagnosing and reporting.
The poor documentation practices can be improved by improving the concept of the clinicians about the biopsy requirements. The receptionist should be trained enough to ensure the availability of the said information. Awareness sessions should be arranged in different wards to encourage the requesting clinicians to provide adequate clinical history along with the specimen. Undergraduate medical students can be educated by teaching them the pre-analytical SOPs of specimen handling. Introducing Electronic Medical Records (EMR) software and specified biopsy RFs may also improve the poor documentation practices.
Recommendations
Future studies may be aimed to determine the errors resulting from the inadequacy of relevant information. Also the results of the practical steps taken to improve the situation must be studied and shared with the medical fraternity.
The reference list from the paper itself. Each links out to its DOI / PubMed record.
- 1Keshwar S Jain N Raut T Singh V Shrestha AA Retrospective Analysis of Concordance Between Clinical and Histopathologic Diagnoses and Completeness of Oral Biopsy Forms at a Tertiary Dental Hospital in Eastern Nepal Int J Dent 2024202412528353 doi:10.1155/2024/25283533939153210.1155/2024/2528353 PMC 11466534 · doi ↗ · pubmed ↗
- 2Comfere NI Peters MS Jenkins S Lackore K Yost K Tilburt J Dermatopathologists'concerns and challenges with clinical information in the skin biopsy requisition form:a mixed-methods study J Cutan Pathol 2015425333345 doi:10.1111/cup.124852575702810.1111/cup.12485 PMC 4701217 · doi ↗ · pubmed ↗
- 3Nakhleh RE Error Reduction in Surgical Pathology Arch Pathol Lab Med 20061305630632 doi:10.5858/2006-130-630-ERISP 1668387710.5858/2006-130-630-ERISP · doi ↗ · pubmed ↗
- 4Nakhleh RE Gephardt G Zarbo RJ Necessity of clinical information in surgical pathology Arch Pathol Lab Med 19991237615619 doi:10.5858/1999-123-0615-NOCIIS 1038891810.5858/1999-123-0615-NOCIIS · doi ↗ · pubmed ↗
- 5Sharma A Gupta G Nishadham V Malik A Kumar A Pasricha S Amendments in surgical pathology reports:An 8-year institutional experience Ann Diagn Pathol 202471152308 doi:10.1016/j.anndiagpath.2024.1523083864080710.1016/j.anndiagpath.2024.152308 · doi ↗ · pubmed ↗
- 6Pathologists Co A Laboratory General Checklist 20204142
- 7Commission TJ National Patient Safety Goals®Effective January 2024 for the Hospital Program 20241
- 8Mishaal Shan Siddiqui SK Dinesh Kumar Saad Khalid Wardah Hassan Mahima Khatri Are We Providing Enough Information to the Pathologists?An Audit of Filling of Histopathology Request Forms for Surgically Resected Tumours J Coll Physicians Surg Pak 20243412484488 doi:10.29271/jcpsp.2024.04.4843857629510.29271/jcpsp.2024.04.484 · doi ↗ · pubmed ↗
